Brentuximab Vedotin for Treatment of Non-Hodgkin Lymphomas: A Systematic Review
Class of 2017 Abstract === This project is related to the article that was later published, available at this link: https://doi.org/10.1016/j.critrevonc.2016.11.009 === Objectives: Brentuximab vedotin (BV) is an antibody-drug conjugate comprising a CD30-directed antibody conjugated to the microtubul...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
The University of Arizona.
2017
|
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.critrevonc.2016.11.009 http://hdl.handle.net/10150/624029 http://arizona.openrepository.com/arizona/handle/10150/624029 |